PCN54 A COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS SECONDARY PROPHYLAXIS WITH COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH DIFFUSE AGGRESSIVE LYMPHOMA RECEIVING CURATIVE-INTENT CHEMOTHERAPY USING ONTARIO HEALTH ECONOMIC DATA
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70232-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70232-1/fulltext
Section Title :
Section Order :
882
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70232-1&doi=10.1016/S1098-3015(10)70232-1